Long-term performance of domestic active-fixation endocardial pacing leads
https://doi.org/10.35336/VA-2023-2-03
EDN: JHSTZO
Abstract
Aim. The aim of the study was to evaluate the long-term results of implantation of domestic endocardial leads (EL) with active fixation ELBI 233C-53 and ELBI 233C-58, implanted in the atrial and ventricular positions, respectively.
Methods. A total of 165 patients were included in the retrospective, single-center study. 239 EL were implanted from 2016 to 2018 (55 ELBI 233C-53 and 184 ELBI 233C-58). The median age was 78 years (43 to 92 years). 846 programming protocols were analyzed, which were carried out on the 1st day after implantation, and then every 6 months. Complications are divided into early (1-7 days) and late (8 days or more).
Results. In the EL ELBI 233C-53 group, there were no statistically significant changes in the pacing parameters during the observation period. There were 6 complications (10.9%): exit block (n=1, 1.8%), dislocation of the EL (n=3, 5.4%), damage to the EL structure (n=2, 3.7%). The number of reoperations was 3 (5.4%). In the ELBI 233C-58 group, a statistically significant increase in the pacing threshold was found (p=0.026). 13 (7.0%) complications were registered, including an increase in the pacing threshold (n=11.6%), exit block (n=1, 0.5%), damage to the EL structure (n=1, 0.5%). The number of reoperations in this group was 2 (1%).
Conclusion. EL ELBI 233C-53 and ELBI 233C-58 demonstrated acceptable pacing parameters and safety during observation. Complications occurred mainly in the first year after implantation. The number of repeated operations was low. There were no deaths caused by complications after lead implantation.
About the Authors
I. O. Repnikov
State Pokrovskaya Hospital
Russian Federation
Russian Federation
Saint-Petersburg, 85 Bolshoy prospect V.O.
I. N. Ginzburg
State Municipal Hospital №31
Russian Federation
Russian Federation
Saint-Petersburg, 3 Dinamo ave
O. L. Gordeev
State Municipal Hospital №31
Russian Federation
Russian Federation
Saint-Petersburg, 3 Dinamo ave
D. F. Egorov
First Saint Petersburg Pavlov’s State Medical University
Russian Federation
Russian Federation
Saint Petersburg, 6-8 Lev Tolstoy str.
References
1. Global number of pacemakers in 2016 and a forecast for 2023 (in million units). Available from: www. statista.com/statistics/800794/pacemakers-market-volume-in-units-worldwide/#statisticContainer
2. Peng H, Sun Z, Zhang H, Ma W. Long-term performance of right ventricular pacing leads: risk factors associated with permanent right ventricular pacing threshold increase. Journal of Interventional Cardiac Electrophysiology. 2019;55: 349-357. https://doi.org/10.1007/s10840018-0481-5.
3. Liu L, Tang J, Peng H, et al. A long-term, prospective, cohort study on the performance of right ventricular pacing leads: comparison of active-fixation with passive-fixation leads. Scientific Reports. 2015;5: 7662. https://doi.org/10.1038/srep07662.
4. Olsen T, Dan Jørgensen O, Nielsen JO, et al. Incidence of device-related infection in 97 750 patients: clinical data from the complete Danish device-cohort (1982-2018). European Heart Journal. 2019;40 (23): 1862-1869. https:// doi.org/10.1093/eurheartj/ehz316.
5. Joung B. Transvenous lead extraction. International Journal of Arrhythmia. 2017;18(4):185-194.
6. de Vries LM, Dijk WA, Hooijschuur AM, et al. Utilisation of cardiac pacemakers over a 20-year period: Results from a nationwide pacemaker registry. Neth Heart J. 2017; 25(1): 47-55. https://doi.org/10.1007/s12471-016-0880-0.
7. Hai-Bo Y, Yaling H. Long-term performance of active fixation pacing leads in right atrium. Heart. 2013; 99:A185-A186.
8. Hao Y, Li Y, Liao D, et al. A comparative analysis of the effectiveness of active versus passive atrial lead fixation in Chinese patients with cardiac implantable electrical devices: a long term, retrospective, observational, single-center study. Current Medical Research and Opinion. 2019; 33(3): 573-578. https://doi.org/10.1080/03007995.2016.1275938.
9. Kistler PM, Liew G, Mond HG. Long‐Term Performance of Active‐Fixation Pacing Leads: A Prospective Study. PACE. 2006;3: 226-230. https://doi.org/10.1111/j.1540-8159.2006.00327.x.
10. Hauser RG, Hayes DL. Increasing hazard of Sprint Fidelis implantable cardioverter- defibrillator lead failure. Heart Rhythm. 2009;6: 605-10. https://doi.org/10.1016/j.hrthm.2009.02.024.
11. Kalmykov VG, Frolov VM, Frolov AV. Endocardial lead implantation. Journal of Arrhythmology. 2000;20: 92-94 (In Russ.)].
12. Hua W, Mond HG, Strathmore N. Chronic SteroidEluting Lead Performance: A Comparison of Atrial and Ventricular Pacing. PACE. 1997;20(1): 17-24. https://doi.org/0.1111/j.1540-8159.1997.tb04807.x.
13. Glikson M, Von Feldt LK, Suman VJ, Hayes D. Clinical surveillance of an active fixation, bipolar, polyurethane insulated pacing lead, Part I: The atrial lead. Pacing Clin Electrophysiol. 1994;17(8): 1399-1404. https://doi.org/10.1111/j.1540-8159.1994.tb02459.x.
14. Glikson M, Von Feldt LK, Suman VJ, et al. Clinical Surveillance of an Active Fixation, Bipolar, Polyurethane Insulated Pacing Lead, Part II: The Ventricular Lead. Pacing Clin Electrophysiol. 1994;17(9): 1499-1502. https://doi.org/10.1111/j.1540-8159.1994.tb01514.x.
15. Fuertes B, Toquero J, Arroyo-Espliguero R, et al. Pacemaker Lead Displacement: Mechanisms and Management. Indian Pacing Electrophysiol J. 2003;3(4): 231-238.
16. Glikson M, Yaacoby E, Feldman S, et al. Randomized comparison of J-shaped and straight atrial screw-in pacing leads. Mayo Clin Proc. 2000; 75(12): 1269-73. https://doi.org/10.4065/75.12.1269.
17. Ohnuki M, Miyataka K, Nakamura T, et al. Long-Term Follow-Up of Endocardial Pacing Leads Implanted with Extrathoracic Subclavian Venous Approach. J Arrhythmia. 2006;22(2): 110-114. https://doi.org/10.4020/jhrs.22.110.
18. Magney JE, Flynn DM, Pasrsons JA, et al. Anatomical Mechanisms Explaining Damage to Pacemaker Leads, Defibrillator Leads, and Failure of Central Venous Catheters Adjacent to the Sternoclavicular Joint. PACE. 1993;16(3): 445457. https://doi.org/10.1111/j.1540-8159.1993.tb01607.x
19. Haghjoo M. Pacing System Malfunction: Evaluation and Troubleshooting. Modern Pacemakers - Present and Future (Ed. Prof. Mithilesh R Das). Rijeka: InTech. 2011: 367-380. https://doi.org/10.5772/13411.
20. Ishikawa T. Effects of Anti-arrhythmic Drugs for Pacing Threshold and Defibrillation Threshold. Journal of Arrhythmia. 2011;27(3): 239-241. https://doi.org/10.1016/S1880-4276(11)80052-9.
Review
For citations:
Repnikov I.O., Ginzburg I.N., Gordeev O.L., Egorov D.F. Long-term performance of domestic active-fixation endocardial pacing leads. Journal of Arrhythmology. 2023;30(2):20-26. https://doi.org/10.35336/VA-2023-2-03. EDN: JHSTZO
Views:
219
Email this article 